A unique inhibitor conformation selectively targets the DNA polymerase PolC of Gram-positive priority pathogens
8.0
来源：
Nature
关键字：
ML brain science
发布时间：
2025-11-06 23:34
摘要：
The study presents a novel class of PolC inhibitors, including ibezapolstat, which targets Gram-positive pathogens like Clostridioides difficile. It highlights the urgent need for new antimicrobials due to rising antibiotic resistance. The research provides cryo-EM structures of PolC in complex with inhibitors, revealing unique binding interactions that could inform the development of more effective treatments. This work lays the groundwork for rational drug design aimed at combating resistant bacterial infections.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分+1.0分
business_impact
1.0分+1.0分
scientific_rigor
1.5分+1.5分
timeliness_innovation
1.5分+1.5分
investment_perspective
2.5分+2.5分
market_value_relevance
1.0分+1.0分
team_institution_background
0.5分+0.5分
technical_barrier_competition
1.0分+1.0分
关键证据
Ibezapolstat is a first-in-class antimicrobial in late-stage clinical development.
The study presents cryo-EM structures revealing a unique binding conformation of inhibitors.
The research addresses the urgent need for new antibiotics against antimicrobial-resistant pathogens.
真实性检查
否
AI评分总结
The study presents a novel class of PolC inhibitors, including ibezapolstat, which targets Gram-positive pathogens like Clostridioides difficile. It highlights the urgent need for new antimicrobials due to rising antibiotic resistance. The research provides cryo-EM structures of PolC in complex with inhibitors, revealing unique binding interactions that could inform the development of more effective treatments. This work lays the groundwork for rational drug design aimed at combating resistant bacterial infections.